| Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 … A Chan, S Delaloge, FA Holmes, B Moy, H Iwata, VJ Harvey, NJ Robert, ... The Lancet Oncology 17 (3), 367-377, 2016 | 633 | 2016 |
| Sexual functioning and body image of patients treated for ovarian cancer D Buković, H Silovski, T Silovski, I Hojsak, K Šakić, Z Hrgović Sexuality and Disability 26, 63-73, 2008 | 72 | 2008 |
| Sexual dysfunction in breast cancer survivors D Buković, J Fajdić, Z Hrgović, M Kaufmann, I Hojsak, T Stancerić Oncology Research and Treatment 28 (1), 29-34, 2005 | 65 | 2005 |
| Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial … A Chan, S Delaloge, FA Holmes, B Moy, H Iwata, VJ Harvey, NJ Robert, ... Journal of Clinical Oncology 33 (15_suppl), 508-508, 2015 | 52 | 2015 |
| ExteNET Study Group Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo … A Chan, S Delaloge, FA Holmes, B Moy, H Iwata, VJ Harvey, NJ Robert, ... Lancet Oncol 17 (3), 367-377, 2016 | 25 | 2016 |
| Development and validation of a novel LC-MS/MS method for the simultaneous determination of abemaciclib, palbociclib, ribociclib, anastrozole, letrozole, and fulvestrant in … L Turković, L Bočkor, O Ekpenyong, T Silovski, M Lovrić, S Crnković, ... Pharmaceuticals 15 (5), 614, 2022 | 19 | 2022 |
| Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure S Kokić, D Buković, M Radman, V Čapkun, N Gabrić, V Lesko, ... Collegium antropologicum 27 (1), 181-187, 2003 | 18 | 2003 |
| Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial FA Holmes, B Moy, S Delaloge, SKL Chia, B Ejlertsen, J Mansi, H Iwata, ... European Journal of Cancer 184, 48-59, 2023 | 15 | 2023 |
| Kliničke upute hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ... Liječnički vjesnik 137 (5-6), 0-0, 2015 | 14 | 2015 |
| HER2 Low breast cancer: a new subtype or a Trojan for cytotoxic drug delivery? M Popović, T Silovski, M Križić, N Dedić Plavetić International journal of molecular sciences 24 (9), 8206, 2023 | 11 | 2023 |
| ASSOCIATION OF BREAST CANCER SYMPTOMS WITH PATIENTS’QUALITY OF LIFE AND DEPRESSION; A CROATIAN CROSS-SECTIONAL STUDY R Šeparović, T Silovski, A Tecić Vuger, Ž Bajić, H Silovski, A Jurić Psychiatria Danubina 31 (suppl. 1), 92-98, 2019 | 10 | 2019 |
| SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA–KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak … N Dedić Plavetić, T Silovski, A Tečić Vuger, M Pavlović, L Vazdar, ... Liječnički vjesnik 140 (3-4), 0-0, 2018 | 9 | 2018 |
| Clinical guidelines for diagnosis, treatment and monitoring of patients with invasive breast cancer–Croatian Oncology Society R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ... Liječnički vjesnik 137 (5-6), 0-0, 2015 | 9 | 2015 |
| Rapid hair depigmentation in patient treated with pazopanib R Šeparović, M Pavlović, T Silovski, AT Vuger Case Reports 2018, bcr-2018-224209, 2018 | 8 | 2018 |
| Kliničke preporuke Hrvatskog društva za internističku onkologiju HLZ-a za dijagnozu, liječenje i praćenje bolesnika/ca oboljelih od melanoma kože D Herceg, D Štulhofer Buzina, R Čeović, S Dotlić, I Ilić, S Smuđ Orehovec, ... Liječnički vjesnik 138 (1-2), 0-0, 2016 | 7 | 2016 |
| Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial FA Holmes, B Moy, S Delaloge, S Chia, B Ejlertsen, J Mansi, H Iwata, ... Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium, 2021 | 6 | 2021 |
| The first wave of the COVID-19 pandemic and its impact on the level of distress in patients with breast cancer, a multicentric study A Budisavljevic, R Kelemenic-Drazin, N Dedic Plavetic, I Kardum Fucak, ... Psychiatria Danubina 33 (suppl 13), 341-349, 2021 | 6 | 2021 |
| Correlation between psychological resilience and burnout syndrome in oncologists amid the Covid-19 pandemic A Budisavljevic, R Kelemenic-Drazin, T Silovski, S Plestina, ND Plavetic Supportive care in cancer 31 (4), 207, 2023 | 5 | 2023 |
| Impact of the COVID-19 outbreak on the level of distress in patients with breast cancer A Budisavljevic, R Kelemenic-Drazin, ND Plavetic, IK Fucak, T Silovski, ... The Breast 56, S85, 2021 | 4 | 2021 |
| Abstract PD3-03: Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: final overall survival analysis from the randomized phase 3 ExteNET trial FA Holmes, B Moy, S Delaloge, S Chia, B Ejlertsen, J Mansi, H Iwata, ... Cancer research 81 (4_Supplement), PD3-03-PD3-03, 2021 | 4 | 2021 |
